PSA-IgM and iXip in the diagnosis and management of prostate cancer: clinical relevance and future potential. A review. Acta Biomedica Atenei Parmensis, Fidenza, Italy, v. 92, n. 6, p. e2021344, 2022. DOI: 10.23750/abm.v92i6.12058. Disponível em: https://mattioli1885journals.com/index.php/actabiomedica/article/view/12058.. Acesso em: 30 jun. 2024.